Head-to-head comparison
altRX vs FitRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy.
From $149/mo (lowest dose rung) sema · From $249/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: States-served list not disclosed
FDAWarning letter issued to Trinity HealthCare Supply, LLC dba altRx in June 2026. See the FDA warning-letter database.
Desk Score
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
$151/mo (quarterly prepay) sema · Verified July 2026
Marked down on: Insurance coordination may not work for all plans
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
FitRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 64/100 (C) for altRX. altRX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
altRX
64/100
C
FitRx
78/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | altRX | FitRx |
|---|---|---|
| Semaglutide | From $149/molowest dose rung$149/mo (starting dose, compounded) | $151/moquarterly prepay$151/mo (quarterly plan, compounded) |
| Tirzepatide | From $249/molowest dose rung$249/mo (starting dose, compounded) | Not listed on FitRx's site (checked July 2026) |
| Coverage | Not listed on altRX's site (checked July 2026) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | The only platform offering all four brand-name GLP-1s plus compounded. | Insured patients seeking brand-name GLP-1 access with compounded fallback. |
| Desk Score | 64/100C | 78/100C+ |
The verdict
Desk pick — FitRxFitRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 64/100 (C) for altRX. altRX still holds its ground where its strengths line up with yours.
Choose altRX if…
The only platform offering all four brand-name GLP-1s plus compounded.
From $149/mo (lowest dose rung) sema · From $249/mo (lowest dose rung) tirz
FDAWarning letter issued to Trinity HealthCare Supply, LLC dba altRx in June 2026. See the FDA warning-letter database.
Choose FitRx if…
Insured patients seeking brand-name GLP-1 access with compounded fallback.
$151/mo (quarterly prepay) sema · All 50 states
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: altRX · FitRx.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- altRX vs CoreAge Rx
- CoreAge Rx vs FitRx
- altRX vs Vytora Health
- FitRx vs Vytora Health
- altRX vs Effecty
- Effecty vs FitRx
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.